Antiaging Quantum Living Inc
alphaspread.comAntiaging Quantum Living Inc (OTC: AAQL) is a New York-incorporated holding company that operates online advertising services and health management businesses through subsidiaries. The company generates revenue from advertisement fees charged to businesses posting on its website, www.dazhong368.com, which targets professional service clients in the Greater New York area, and from technical service fees and health consulting services provided through its China-based subsidiaries under the "Dao Ling Doctor" brand. Total revenue was $817,898 for the fiscal year ended March 31, 2025, up from $7,499 in the fiscal year ended March 31, 2024. The company reported a net loss of $720,409 for the fiscal year ended March 31, 2025, with operating expenses of $1,218,476 exceeding gross profit of $428,517. Incorporated in New York on December 29, 2014, the company has operated under several names and business models. Barry Wan serves as CEO and CFO, having acquired controlling interest in April 2023.
Products & Services
Online advertising platform (www.dazhong368.com) serving real estate, accounting, legal, and other professional service advertisers in the Greater New York area. China-based health management services under the "Dao Ling Doctor" brand, including technical development and maintenance services to distributors (Dao Ling Doctor Zhejiang) and health consulting services excluding diagnosis and treatment (Dao Ling Doctor Huzhou).
Revenue Model
Two revenue streams as of the 10-K filed 2025-07-02: advertising fees from businesses posting on www.dazhong368.com targeting the Greater New York area, and technical service fees plus health consulting fees from China-based subsidiaries Dao Ling Doctor Zhejiang and Dao Ling Doctor Huzhou. Total revenue was $817,898 for FY2025 versus $7,499 for FY2024. Gross margin was 52.4% in FY2025 versus 89.7% in FY2024.
Customers & Markets
Professional individuals and companies in the Greater New York area seeking advertising for real estate, accounting, legal, and related services. Distributors of the "Dao Ling Doctor" brand in the Asia-Pacific and Chinese markets, targeted following a board resolution dated December 29, 2023.
Geographic Exposure
United States (Greater New York area) for online advertising operations. China (Zhejiang province, including Hangzhou and Huzhou) for health management subsidiaries established following December 29, 2023 board resolution. British Virgin Islands and Hong Kong holding entities in the subsidiary structure.
Source: SEC 10-K, filed 2025-07-02
Financial Snapshot
Loading...
